George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.44
Bid: 41.60
Ask: 41.70
Change: 0.56 (1.37%)
Spread: 0.10 (0.24%)
Open: 41.36
High: 41.70
Low: 40.84
Prev. Close: 40.88
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

13 Jan 2020 07:00

RNS Number : 5048Z
Assura PLC
13 January 2020
 

13 January 2020

Assura plc

 

Trading Update

For the third quarter ending 31 December 2019

 

Continued strong performance

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the third quarter ending 31 December 2019.

 

Jonathan Murphy, CEO, said:

 

"Assura continued to make strong progress in the third quarter. We expanded our market-leading portfolio with the acquisition of six high-quality assets and completed our third development of the year in Stow-on-the-Wold. We also grew our immediate pipeline of acquisition and development opportunities, reinforcing what was already our strongest in 10 years, to £252 million including 13 developments currently on site."

 

"With the new Government enshrining in law increased funding for the NHS and taking forward the Health Infrastructure Plan, better primary care facilities for patients, staff and services are at the heart of the agenda. In this context, Assura is well positioned to deliver high-quality assets and value for money for the NHS."

 

Building the portfolio

·; Current portfolio of 563 properties.

·; Development completed at Stow-on-the-Wold, taking total to three completed year to date at a total cost of £11.8 million.

·; Currently on site with 13 developments at the period end with a total development cost of £66 million.

·; Six acquisitions completed in the period at a cost of £31.1 million; four disposals made for cash proceeds of £1.0 million.

 

Expanding the pipeline

·; Immediate development pipeline further increased to £90 million, up from £72 million at September 2019.

·; Immediate acquisitions pipeline further increased to £96 million, up from £65 million at September 2019.

·; Total immediate pipeline, including on site developments, worth £252 million, up from £206 million at September 2019.

 

Growing the rent roll

·; Five lease re-gears completed in the quarter taking cumulative year-to-date re-gears to 18. These leases represent £1.7 million of the Group's rent roll, adding a weighted average of 10.2 years WAULT to those 18 leases.

·; Annualised rent roll at £105.8 million taking account of additions, disposals and rent reviews.

 

Robust balance sheet

·; As at 31 December 2019 gross debt stood at £787 million with undrawn facilities of £280 million.

 

As previously announced, the quarterly dividend has been increased to 0.697 pence per share with effect from January 2020. This is equivalent to 2.788 pence per share on an annualised basis.

 

ENDS

 

 

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFERLEIILII
Date   Source Headline
2nd Oct 20171:07 pmRNSNotification of Major Interests in Shares
2nd Oct 20177:00 amRNSTrading Update
25th Sep 20177:00 amRNSChief Financial Officer
21st Sep 201712:21 pmRNSScrip Calculation Price
11th Sep 20174:23 pmRNSNotification of Major Interests in Shares
8th Sep 20175:20 pmRNSPDMR Notification
7th Sep 20177:00 amRNSNotice of Dividend - Property Income Distribution
1st Sep 201711:42 amRNSTotal Voting Rights
1st Sep 201710:30 amRNSExercise of Nil Cost Options under VCP
30th Aug 20177:00 amRNSAdditional Listing
21st Aug 20171:44 pmRNSAppointment of Joint Corporate Broker
17th Aug 201712:05 pmRNSNotification of Major Interest in Shares
4th Aug 20177:00 amRNSAppointment of Chief Financial Officer
1st Aug 20177:00 amRNSTotal Voting Rights
19th Jul 20174:41 pmRNSNotification of Transactions by PDMRs
18th Jul 20172:27 pmRNSResult of AGM
18th Jul 20177:00 amRNSTrading Update
17th Jul 20177:00 amRNSScrip Dividend Declaration
3rd Jul 20179:20 amRNSCorrection of Total Voting Rights
3rd Jul 20177:00 amRNSTotal Voting Rights
22nd Jun 201711:14 amRNSScrip Calculation Price
22nd Jun 201710:14 amRNSNotification of Major Interests in Shares
22nd Jun 201710:11 amRNSNotification of Major Interests in Shares
20th Jun 20174:52 pmRNSResults of Placing
20th Jun 20177:00 amRNSProposed equity Issue of new ordinary shares
16th Jun 20174:00 pmRNSAnnual Report and Notice of AGM
16th Jun 20173:12 pmRNSNotification of Major Interests in Shares
13th Jun 20172:56 pmRNSNotification of Major Interests in Shares
8th Jun 20177:00 amRNSNotice of Dividend
5th Jun 20174:55 pmRNSNotification of transaction by PDMR
30th May 20177:00 amRNSDirector Declaration
24th May 201711:29 amRNSCorrection of Dividend Information
23rd May 20177:00 amRNSAssura Full Year Results
12th May 201711:00 amRNSNotification of Major Interests in Shares
11th May 20172:46 pmRNSNotification of Major Interests in Shares
2nd May 20177:00 amRNSTotal Voting Rights
18th Apr 20177:00 amRNSScrip Dividend Declaration
11th Apr 20174:29 pmRNSNotification of Major Interest in Shares
24th Mar 20174:15 pmRNSScrip Calculation Price
9th Mar 20177:00 amRNSNotice of Dividend
27th Feb 20177:00 amRNSAppointment of CEO
17th Feb 20173:07 pmRNSNotification of Major Interest in Shares
1st Feb 201712:54 pmRNSTotal Voting Rights
1st Feb 20177:00 amRNSTrading Update
26th Jan 20179:18 amRNSNotification of Major Interest in Shares
18th Jan 20177:00 amRNSNotification of Transaction by PDMR
16th Jan 20177:00 amRNSScrip Dividend Declaration
22nd Dec 20167:00 amRNSScrip Calculation Price
8th Dec 20167:00 amRNSNotice of Dividend
22nd Nov 20167:00 amRNSInterim Results 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.